comparemela.com

Latest Breaking News On - Euronext growth - Page 6 : comparemela.com

GLOBAL BIOENERGIES: Progress on cosmetics plant project: completion of the basic engineering phase and success of the related test campaign

PRESS RELEASE Progress on cosmetics plant project: completion of the basic engineering phase and success of the related test campaign Evry, 29 May 2024 - 05:45 p.m.: Global Bioenergies has successfully

Paris
France-general
France
Roland-desvignes
Nicolas-merigeau
Louis-victor-delouvrier
Linkedin
Global-bioenergies
Industrial-director
Global-bioenergie
Sustainable-aviation-fuels
Euronext-growth

Predilife : PREDILIFE STRENGTHENS ITS ASSETS WITH THE ISSUANCE OF A PATENT FOR ITS AI METHOD

Predilife : PREDILIFE STRENGTHENS ITS ASSETS WITH THE ISSUANCE OF A PATENT FOR ITS AI METHOD
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United-states
France
Villejuif
France-general
French
American
Sorbonne-university
Breast-cancer-surveillance-consortium
Institut-telecom
European-union
European-patent-office

PREDILIFE STRENGTHENS ITS ASSETS WITH THE ISSUANCE OF A PATENT FOR ITS AI METHOD

PRESS RELEASE MAY 29, 2024 . PREDILIFE STRENGTHENS ITS ASSETS WITH THE ISSUANCE OF A PATENT FOR ITS AI METHOD Villejuif, France - May 29, 2024 at 6:30 p.m. CET - PREDILIFE (Euronext Growth: ALPRE

Villejuif
France-general
France
United-states
American
French
European-patent-office
Breast-cancer-surveillance-consortium
European-union
Sorbonne-university
Institut-telecom

Median Technologies : Inside Information / Other news releases

Press release - For immediate release May 29, 2024 - 5:45 pm CEST Median Technologies to participate in the 2024 ASCO.

Mccormick-place
Illinois
United-states
Chicago
China
France
French
American
Sophia-antipolis
American-society-of-clinical-oncology
Clinical-oncology
Annual-meeting

Cellectis' Annual Shareholders General Meeting to be Held on June 28, 2024

NEW YORK, May 29, 2024 Cellectis , a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, announced today that it will.

New-york
United-states
Paris
France-general
France
North-carolina
Raleigh
Patricia-sosa-navarro
Arthur-stril
Pascalyne-wilson
Ashleyr-robinson
Cellectis-the-company-euronext-growth

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.